Advanced kidney cancer: treating the elderly.

about

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.Renal Cancer in the Elderly.Recent advances in cancer surgery in older patients.

P2860

Q34660431-7F075130-BDA6-4E1B-8401-F46458A923A0 Q38682520-F80C7517-A105-4B7E-BEFA-95DDD59D4FD0 Q42338971-CF0C42F1-B639-4A9B-BAF3-F3C73A8A921C

P2860

Advanced kidney cancer: treating the elderly.

Item

http://www.wikidata.org/entity/Q38162249

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Advanced kidney cancer: treating the elderly.

@en

type

Item

label

Advanced kidney cancer: treating the elderly.

@en

prefLabel

Advanced kidney cancer: treating the elderly.

@en

P1476

Advanced kidney cancer: treating the elderly.

@en

P2093

Fable Zustovich

http://www.w3.org/2001/XMLSchema#string

Giacomo Novara

http://www.w3.org/2001/XMLSchema#string

P2860

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.

Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.

Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

P304

1389-1398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2013.846095

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24224483

http://www.w3.org/2001/XMLSchema#string

Advanced kidney cancer: treating the elderly.

about

P2860

P2860

Advanced kidney cancer: treating the elderly.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698